Key Insights
The European In Vitro Diagnostics (IVD) market is poised for substantial growth, projecting a robust market size of USD 21.19 billion in 2025, with a projected CAGR of 7.9% through 2033. This expansion is fueled by a confluence of factors, including advancements in diagnostic technologies, an increasing prevalence of chronic and infectious diseases across the continent, and a growing emphasis on personalized medicine and early disease detection. The demand for highly accurate and rapid diagnostic solutions, particularly in areas like molecular diagnostics and immunoassays, is a significant driver. Furthermore, an aging European population and rising healthcare expenditure contribute to the sustained demand for sophisticated IVD products and services, enabling better patient outcomes and more efficient healthcare delivery. The market is witnessing a strong push towards automated and integrated diagnostic systems, enhancing laboratory throughput and reducing turnaround times, which are crucial in critical care settings.
European In Vitro Diagnostics Market Market Size (In Billion)
The competitive landscape of the European IVD market is characterized by the presence of major global players and innovative regional companies, all vying for market share through strategic partnerships, mergers, and acquisitions. Key segments such as clinical chemistry and molecular diagnostics are expected to dominate, driven by their widespread application in disease screening, diagnosis, and monitoring. The increasing adoption of disposable IVD devices is also a notable trend, offering enhanced convenience and reduced risk of contamination, particularly in point-of-care settings. However, certain restraints, such as stringent regulatory frameworks and the high cost of advanced diagnostic equipment, may present challenges. Despite these, the overarching trend points towards continued innovation and market expansion, driven by the imperative for improved healthcare diagnostics and patient management across Europe.
European In Vitro Diagnostics Market Company Market Share
Gain unparalleled insights into the dynamic European In Vitro Diagnostics (IVD) market with this in-depth report. Spanning from 2019 to 2033, with a base and estimated year of 2025, this study provides critical data and strategic analysis for industry stakeholders. Discover market size estimations in billions, CAGR projections, and key trends shaping the future of IVD across Europe. This report is your essential guide to understanding market concentration, innovation drivers, regulatory landscapes, and the competitive strategies of major players like Becton Dickinson and Company, BioMerieux SA, Siemens Healthcare, Thermo Fisher Scientific Inc., and Roche Diagnostics.
European In Vitro Diagnostics Market Market Structure & Innovation Trends
The European IVD market is characterized by a moderate to high level of concentration, with a few large global players holding significant market shares, particularly in clinical chemistry and immunoassay segments. Innovation is a key driver, fueled by advancements in molecular diagnostics, personalized medicine, and point-of-care testing. Regulatory frameworks, primarily driven by the In Vitro Diagnostic Regulation (IVDR) in the EU, are evolving, leading to increased scrutiny and a need for robust compliance. Product substitutes are emerging, especially in areas where technological advancements offer more accessible or efficient diagnostic solutions. End-user demographics are shifting, with a growing demand for rapid, accurate, and decentralized testing. Mergers and acquisitions (M&A) activity remains a significant aspect of market consolidation and strategic expansion, with deal values influencing market share dynamics. For instance, recent M&A activities have focused on acquiring companies with strong portfolios in molecular diagnostics and digital health solutions. The market is projected to witness continued consolidation as companies seek to expand their product offerings and geographic reach.
European In Vitro Diagnostics Market Market Dynamics & Trends
The European IVD market is experiencing robust growth, driven by an aging population, increasing prevalence of chronic and infectious diseases, and a heightened awareness of early disease detection. Technological advancements are continuously disrupting the market, with the rise of next-generation sequencing, liquid biopsies, and artificial intelligence-powered diagnostic tools enhancing precision and speed. Consumer preferences are leaning towards convenient, patient-centric diagnostic solutions, including home-use IVD devices and point-of-care testing (POCT) platforms, driving the demand for disposable IVD devices. Competitive dynamics are intense, with companies vying for market dominance through product innovation, strategic partnerships, and aggressive marketing strategies. The market penetration of advanced diagnostic technologies is steadily increasing, particularly in molecular diagnostics and immuno diagnostics, areas experiencing significant CAGR. The growing demand for personalized medicine and companion diagnostics is also a major catalyst. Furthermore, the increasing burden of infectious diseases and the ongoing need for effective diagnostic tools for managing conditions like diabetes and cancer contribute significantly to market expansion. The push towards digitalization in healthcare, enabling seamless data integration and remote diagnostics, is another pivotal trend influencing market dynamics.
Dominant Regions & Segments in European In Vitro Diagnostics Market
Germany, France, and the UK are the dominant regions within the European IVD market, driven by advanced healthcare infrastructure, high R&D investments, and favorable reimbursement policies. The Clinical Chemistry segment holds a substantial market share due to its widespread use in routine health monitoring. Molecular Diagnostics is exhibiting the highest growth rate, fueled by advancements in genetic sequencing and the increasing demand for infectious disease and cancer diagnostics.
Test Type Dominance:
- Clinical Chemistry: Dominates due to its broad application in routine diagnostics. Economic policies supporting healthcare infrastructure and an aging population are key drivers.
- Molecular Diagnostics: Fastest-growing segment, driven by technological innovation and demand for precision medicine. Increased funding for genetic research and infectious disease surveillance are crucial.
- Immuno Diagnostics: Strong presence, particularly for infectious disease and autoimmune disease testing. Public health initiatives and the prevalence of autoimmune disorders contribute to its dominance.
Product Dominance:
- Reagents: Constitute the largest share due to their consumable nature and frequent use across various test types. Consistent demand from diagnostic laboratories and hospitals fuels this segment.
- Instruments: High initial investment but essential for performing complex diagnostic tests. Technological advancements and demand for automation drive instrument sales.
Usability Dominance:
- Disposable IVD Devices: Growing rapidly due to their convenience, reduced risk of cross-contamination, and suitability for point-of-care settings. Increased adoption of home testing kits and the IVDR's focus on safety are key factors.
Application Dominance:
- Infectious Disease: Historically significant, especially post-pandemic, with ongoing demand for rapid and accurate diagnostics. Global health initiatives and pandemic preparedness are major drivers.
- Cancer/Oncology: Rapidly expanding due to advancements in cancer diagnostics, liquid biopsies, and personalized treatment approaches. Increased cancer screening programs and R&D funding are critical.
- Diabetes: Consistent demand driven by the high and increasing prevalence of diabetes across Europe. Technological advancements in glucose monitoring and HbA1c testing contribute to segment growth.
End User Dominance:
- Diagnostic Laboratories: The largest end-user segment, accounting for a significant portion of IVD test volumes. Established infrastructure and specialized expertise drive their dominance.
- Hospitals and Clinics: Increasing adoption of in-house diagnostic testing, particularly in critical care and point-of-care settings. Growing patient volumes and the need for immediate results bolster this segment.
European In Vitro Diagnostics Market Product Innovations
Product innovation in the European IVD market is centered on enhancing accuracy, speed, and accessibility. Companies are developing advanced molecular diagnostic platforms for rapid pathogen detection, such as MGI Tech's DNBSeq-G99 sequencer, enabling precise genetic substance sequencing. Immunoassay automation is also a key area, with BioMérieux SA's Vidas Kube system offering automated solutions for immunochemistry and infectious disease diagnostics. Furthermore, there's a strong focus on integrated diagnostic systems and user-friendly cartridges, exemplified by Noul Co., Ltd.'s miLab Cartridge CER and miLab Cartridge BCM, expanding product lines in next-generation diagnostic testing. These innovations aim to reduce turnaround times, improve diagnostic yields, and broaden the scope of applications, providing a competitive edge and addressing unmet clinical needs.
Report Scope & Segmentation Analysis
This report meticulously segments the European In Vitro Diagnostics market across Test Types including Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, and Other Test Types. Product segmentation covers Instruments, Reagents, and Other Products. Usability is analyzed through Disposable IVD Devices and Reusable IVD Devices. Applications explored are Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications. End Users are categorized into Diagnostic Laboratories, Hospitals and Clinics, and Other End Users. Each segment is projected to exhibit varying growth rates, with Molecular Diagnostics and Infectious Disease applications expected to lead in market size and growth within the forecast period (2025-2033). Competitive dynamics within each segment are shaped by technological adoption and regional healthcare policies.
Key Drivers of European In Vitro Diagnostics Market Growth
Several key factors are propelling the growth of the European IVD market. The increasing prevalence of chronic and infectious diseases, coupled with an aging population, drives demand for diagnostic testing. Technological advancements, particularly in molecular diagnostics and AI-powered analytics, are enabling more precise and rapid diagnoses. Favorable reimbursement policies and increasing healthcare expenditure across European nations also contribute significantly. Furthermore, the growing emphasis on preventive healthcare and early disease detection encourages the adoption of advanced IVD solutions.
Challenges in the European In Vitro Diagnostics Market Sector
Despite strong growth potential, the European IVD market faces several challenges. The stringent regulatory landscape, especially the implementation of the IVDR, presents significant compliance hurdles and can delay product approvals. Supply chain disruptions, as seen in recent global events, can impact the availability of raw materials and finished products. High R&D costs associated with developing novel diagnostic technologies, alongside intense competition from established and emerging players, also pose challenges. Furthermore, variations in healthcare infrastructure and reimbursement policies across different European countries can lead to market fragmentation.
Emerging Opportunities in European In Vitro Diagnostics Market
The European IVD market presents numerous emerging opportunities. The growing demand for point-of-care testing (POCT) and home-use diagnostic devices offers significant growth potential, driven by convenience and accessibility. The expansion of personalized medicine, requiring sophisticated companion diagnostics, is creating new market niches. The increasing focus on infectious disease surveillance and preparedness, especially post-pandemic, presents opportunities for rapid diagnostic solutions. Digitalization of healthcare, including AI-driven diagnostics and data analytics, opens avenues for integrated diagnostic platforms and improved patient management. Furthermore, the expanding market for companion diagnostics in oncology and rare diseases represents a substantial growth avenue.
Leading Players in the European In Vitro Diagnostics Market Market
- Abbott Laboratories
- Bio-Rad Laboratories Inc
- BioMerieux SA
- Danaher Corporation (Beckman Coulter Inc)
- Diasorin S p A
- Hologic Inc
- Illumina Inc
- QIAGEN
- Roche Diagnostics
- Segments
- Siemens Healthcare
- Sysmex Corporation
- Tesa SE
- Thermo Fisher Scientific Inc.
Key Developments in European In Vitro Diagnostics Market Industry
- March 2023: MGI Tech Co., Ltd. received the CE mark for the DNBSeq-G99 sequencer, enhancing capabilities for precise genetic substance sequencing.
- December 2022: BioMérieux SA received the CE mark for its Vidas Kube automated immunoassay system, improving diagnostics for immunochemistry, infectious diseases, and food industry pathogens.
- September 2022: Noul Co., Ltd. received the CE-IVD mark for two next-generation diagnostic testing products, miLab Cartridge CER and miLab Cartridge BCM, expanding its in-vitro diagnostics systems product line.
Future Outlook for European In Vitro Diagnostics Market Market
The future outlook for the European IVD market is exceptionally promising, characterized by sustained growth and transformative innovations. The continued aging of the European population and the persistent rise in chronic and infectious diseases will ensure a robust demand for diagnostic solutions. The increasing adoption of AI and machine learning in diagnostics will lead to more accurate and efficient disease detection and management. The market will likely witness further consolidation and strategic partnerships as companies seek to leverage synergies and expand their global reach. The growing importance of personalized medicine and companion diagnostics will drive the development of highly specialized IVD products, further segmenting the market and offering niche opportunities for agile players. The focus on decentralized diagnostics, including POCT and home-use devices, will continue to expand, democratizing access to healthcare.
European In Vitro Diagnostics Market Segmentation
-
1. Test Type
- 1.1. Clinical Chemistry
- 1.2. Molecular Diagnostics
- 1.3. Hematology
- 1.4. Immuno Diagnostics
- 1.5. Other Test Types
-
2. Product
- 2.1. Instrument
- 2.2. Reagents
- 2.3. Other Products
-
3. Usability
- 3.1. Disposable IVD Devices
- 3.2. Reusable IVD Devices
-
4. Application
- 4.1. Infectious Disease
- 4.2. Diabetes
- 4.3. Cancer/Oncology
- 4.4. Cardiology
- 4.5. Autoimmune Disease
- 4.6. Nephrology
- 4.7. Other Applications
-
5. End User
- 5.1. Diagnostic Laboratories
- 5.2. Hospitals and Clinics
- 5.3. Other End Users
European In Vitro Diagnostics Market Segmentation By Geography
- 1. Germany
- 2. United Kingdom
- 3. France
- 4. Italy
- 5. Spain
- 6. Rest of Europe
European In Vitro Diagnostics Market Regional Market Share
Geographic Coverage of European In Vitro Diagnostics Market
European In Vitro Diagnostics Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.9% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. High Prevalence of Chronic Diseases; Increasing Demand for Point-of-care Diagnostics; Technological Advancements in In-Vitro Diagnostics Devices
- 3.3. Market Restrains
- 3.3.1. Stringent Regulations; Cumbersome Reimbursement Procedures
- 3.4. Market Trends
- 3.4.1. The Instrument Segment is Expected to Hold a Major Share in the Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Test Type
- 5.1.1. Clinical Chemistry
- 5.1.2. Molecular Diagnostics
- 5.1.3. Hematology
- 5.1.4. Immuno Diagnostics
- 5.1.5. Other Test Types
- 5.2. Market Analysis, Insights and Forecast - by Product
- 5.2.1. Instrument
- 5.2.2. Reagents
- 5.2.3. Other Products
- 5.3. Market Analysis, Insights and Forecast - by Usability
- 5.3.1. Disposable IVD Devices
- 5.3.2. Reusable IVD Devices
- 5.4. Market Analysis, Insights and Forecast - by Application
- 5.4.1. Infectious Disease
- 5.4.2. Diabetes
- 5.4.3. Cancer/Oncology
- 5.4.4. Cardiology
- 5.4.5. Autoimmune Disease
- 5.4.6. Nephrology
- 5.4.7. Other Applications
- 5.5. Market Analysis, Insights and Forecast - by End User
- 5.5.1. Diagnostic Laboratories
- 5.5.2. Hospitals and Clinics
- 5.5.3. Other End Users
- 5.6. Market Analysis, Insights and Forecast - by Region
- 5.6.1. Germany
- 5.6.2. United Kingdom
- 5.6.3. France
- 5.6.4. Italy
- 5.6.5. Spain
- 5.6.6. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Test Type
- 6. Germany European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Test Type
- 6.1.1. Clinical Chemistry
- 6.1.2. Molecular Diagnostics
- 6.1.3. Hematology
- 6.1.4. Immuno Diagnostics
- 6.1.5. Other Test Types
- 6.2. Market Analysis, Insights and Forecast - by Product
- 6.2.1. Instrument
- 6.2.2. Reagents
- 6.2.3. Other Products
- 6.3. Market Analysis, Insights and Forecast - by Usability
- 6.3.1. Disposable IVD Devices
- 6.3.2. Reusable IVD Devices
- 6.4. Market Analysis, Insights and Forecast - by Application
- 6.4.1. Infectious Disease
- 6.4.2. Diabetes
- 6.4.3. Cancer/Oncology
- 6.4.4. Cardiology
- 6.4.5. Autoimmune Disease
- 6.4.6. Nephrology
- 6.4.7. Other Applications
- 6.5. Market Analysis, Insights and Forecast - by End User
- 6.5.1. Diagnostic Laboratories
- 6.5.2. Hospitals and Clinics
- 6.5.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Test Type
- 7. United Kingdom European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Test Type
- 7.1.1. Clinical Chemistry
- 7.1.2. Molecular Diagnostics
- 7.1.3. Hematology
- 7.1.4. Immuno Diagnostics
- 7.1.5. Other Test Types
- 7.2. Market Analysis, Insights and Forecast - by Product
- 7.2.1. Instrument
- 7.2.2. Reagents
- 7.2.3. Other Products
- 7.3. Market Analysis, Insights and Forecast - by Usability
- 7.3.1. Disposable IVD Devices
- 7.3.2. Reusable IVD Devices
- 7.4. Market Analysis, Insights and Forecast - by Application
- 7.4.1. Infectious Disease
- 7.4.2. Diabetes
- 7.4.3. Cancer/Oncology
- 7.4.4. Cardiology
- 7.4.5. Autoimmune Disease
- 7.4.6. Nephrology
- 7.4.7. Other Applications
- 7.5. Market Analysis, Insights and Forecast - by End User
- 7.5.1. Diagnostic Laboratories
- 7.5.2. Hospitals and Clinics
- 7.5.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Test Type
- 8. France European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Test Type
- 8.1.1. Clinical Chemistry
- 8.1.2. Molecular Diagnostics
- 8.1.3. Hematology
- 8.1.4. Immuno Diagnostics
- 8.1.5. Other Test Types
- 8.2. Market Analysis, Insights and Forecast - by Product
- 8.2.1. Instrument
- 8.2.2. Reagents
- 8.2.3. Other Products
- 8.3. Market Analysis, Insights and Forecast - by Usability
- 8.3.1. Disposable IVD Devices
- 8.3.2. Reusable IVD Devices
- 8.4. Market Analysis, Insights and Forecast - by Application
- 8.4.1. Infectious Disease
- 8.4.2. Diabetes
- 8.4.3. Cancer/Oncology
- 8.4.4. Cardiology
- 8.4.5. Autoimmune Disease
- 8.4.6. Nephrology
- 8.4.7. Other Applications
- 8.5. Market Analysis, Insights and Forecast - by End User
- 8.5.1. Diagnostic Laboratories
- 8.5.2. Hospitals and Clinics
- 8.5.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Test Type
- 9. Italy European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Test Type
- 9.1.1. Clinical Chemistry
- 9.1.2. Molecular Diagnostics
- 9.1.3. Hematology
- 9.1.4. Immuno Diagnostics
- 9.1.5. Other Test Types
- 9.2. Market Analysis, Insights and Forecast - by Product
- 9.2.1. Instrument
- 9.2.2. Reagents
- 9.2.3. Other Products
- 9.3. Market Analysis, Insights and Forecast - by Usability
- 9.3.1. Disposable IVD Devices
- 9.3.2. Reusable IVD Devices
- 9.4. Market Analysis, Insights and Forecast - by Application
- 9.4.1. Infectious Disease
- 9.4.2. Diabetes
- 9.4.3. Cancer/Oncology
- 9.4.4. Cardiology
- 9.4.5. Autoimmune Disease
- 9.4.6. Nephrology
- 9.4.7. Other Applications
- 9.5. Market Analysis, Insights and Forecast - by End User
- 9.5.1. Diagnostic Laboratories
- 9.5.2. Hospitals and Clinics
- 9.5.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Test Type
- 10. Spain European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Test Type
- 10.1.1. Clinical Chemistry
- 10.1.2. Molecular Diagnostics
- 10.1.3. Hematology
- 10.1.4. Immuno Diagnostics
- 10.1.5. Other Test Types
- 10.2. Market Analysis, Insights and Forecast - by Product
- 10.2.1. Instrument
- 10.2.2. Reagents
- 10.2.3. Other Products
- 10.3. Market Analysis, Insights and Forecast - by Usability
- 10.3.1. Disposable IVD Devices
- 10.3.2. Reusable IVD Devices
- 10.4. Market Analysis, Insights and Forecast - by Application
- 10.4.1. Infectious Disease
- 10.4.2. Diabetes
- 10.4.3. Cancer/Oncology
- 10.4.4. Cardiology
- 10.4.5. Autoimmune Disease
- 10.4.6. Nephrology
- 10.4.7. Other Applications
- 10.5. Market Analysis, Insights and Forecast - by End User
- 10.5.1. Diagnostic Laboratories
- 10.5.2. Hospitals and Clinics
- 10.5.3. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Test Type
- 11. Rest of Europe European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Test Type
- 11.1.1. Clinical Chemistry
- 11.1.2. Molecular Diagnostics
- 11.1.3. Hematology
- 11.1.4. Immuno Diagnostics
- 11.1.5. Other Test Types
- 11.2. Market Analysis, Insights and Forecast - by Product
- 11.2.1. Instrument
- 11.2.2. Reagents
- 11.2.3. Other Products
- 11.3. Market Analysis, Insights and Forecast - by Usability
- 11.3.1. Disposable IVD Devices
- 11.3.2. Reusable IVD Devices
- 11.4. Market Analysis, Insights and Forecast - by Application
- 11.4.1. Infectious Disease
- 11.4.2. Diabetes
- 11.4.3. Cancer/Oncology
- 11.4.4. Cardiology
- 11.4.5. Autoimmune Disease
- 11.4.6. Nephrology
- 11.4.7. Other Applications
- 11.5. Market Analysis, Insights and Forecast - by End User
- 11.5.1. Diagnostic Laboratories
- 11.5.2. Hospitals and Clinics
- 11.5.3. Other End Users
- 11.1. Market Analysis, Insights and Forecast - by Test Type
- 12. Competitive Analysis
- 12.1. Market Share Analysis 2025
- 12.2. Company Profiles
- 12.2.1 Becton Dickinson and Company
- 12.2.1.1. Overview
- 12.2.1.2. Products
- 12.2.1.3. SWOT Analysis
- 12.2.1.4. Recent Developments
- 12.2.1.5. Financials (Based on Availability)
- 12.2.2 BioMerieux SA
- 12.2.2.1. Overview
- 12.2.2.2. Products
- 12.2.2.3. SWOT Analysis
- 12.2.2.4. Recent Developments
- 12.2.2.5. Financials (Based on Availability)
- 12.2.3 Tesa SE
- 12.2.3.1. Overview
- 12.2.3.2. Products
- 12.2.3.3. SWOT Analysis
- 12.2.3.4. Recent Developments
- 12.2.3.5. Financials (Based on Availability)
- 12.2.4 Bio-Rad Laboratories Inc
- 12.2.4.1. Overview
- 12.2.4.2. Products
- 12.2.4.3. SWOT Analysis
- 12.2.4.4. Recent Developments
- 12.2.4.5. Financials (Based on Availability)
- 12.2.5 Illumina Inc
- 12.2.5.1. Overview
- 12.2.5.2. Products
- 12.2.5.3. SWOT Analysis
- 12.2.5.4. Recent Developments
- 12.2.5.5. Financials (Based on Availability)
- 12.2.6 Siemens Healthcare
- 12.2.6.1. Overview
- 12.2.6.2. Products
- 12.2.6.3. SWOT Analysis
- 12.2.6.4. Recent Developments
- 12.2.6.5. Financials (Based on Availability)
- 12.2.7 Hologic Inc
- 12.2.7.1. Overview
- 12.2.7.2. Products
- 12.2.7.3. SWOT Analysis
- 12.2.7.4. Recent Developments
- 12.2.7.5. Financials (Based on Availability)
- 12.2.8 Thermo Fisher Scientific Inc
- 12.2.8.1. Overview
- 12.2.8.2. Products
- 12.2.8.3. SWOT Analysis
- 12.2.8.4. Recent Developments
- 12.2.8.5. Financials (Based on Availability)
- 12.2.9 Abbott Laboratories
- 12.2.9.1. Overview
- 12.2.9.2. Products
- 12.2.9.3. SWOT Analysis
- 12.2.9.4. Recent Developments
- 12.2.9.5. Financials (Based on Availability)
- 12.2.10 Diasorin S p A
- 12.2.10.1. Overview
- 12.2.10.2. Products
- 12.2.10.3. SWOT Analysis
- 12.2.10.4. Recent Developments
- 12.2.10.5. Financials (Based on Availability)
- 12.2.11 Danaher Corporation (Beckman Coulter Inc)
- 12.2.11.1. Overview
- 12.2.11.2. Products
- 12.2.11.3. SWOT Analysis
- 12.2.11.4. Recent Developments
- 12.2.11.5. Financials (Based on Availability)
- 12.2.12 Sysmex Corporation
- 12.2.12.1. Overview
- 12.2.12.2. Products
- 12.2.12.3. SWOT Analysis
- 12.2.12.4. Recent Developments
- 12.2.12.5. Financials (Based on Availability)
- 12.2.13 QIAGEN
- 12.2.13.1. Overview
- 12.2.13.2. Products
- 12.2.13.3. SWOT Analysis
- 12.2.13.4. Recent Developments
- 12.2.13.5. Financials (Based on Availability)
- 12.2.14 Roche Diagnostics
- 12.2.14.1. Overview
- 12.2.14.2. Products
- 12.2.14.3. SWOT Analysis
- 12.2.14.4. Recent Developments
- 12.2.14.5. Financials (Based on Availability)
- 12.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: European In Vitro Diagnostics Market Revenue Breakdown (billion, %) by Product 2025 & 2033
- Figure 2: European In Vitro Diagnostics Market Share (%) by Company 2025
List of Tables
- Table 1: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 2: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 3: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 4: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 5: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 6: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 7: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 8: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 9: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 10: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 11: European In Vitro Diagnostics Market Revenue billion Forecast, by Region 2020 & 2033
- Table 12: European In Vitro Diagnostics Market Volume K Unit Forecast, by Region 2020 & 2033
- Table 13: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 14: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 15: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 16: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 17: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 18: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 19: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 20: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 21: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 22: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 23: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 24: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 25: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 26: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 27: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 28: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 29: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 30: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 31: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 32: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 33: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 34: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 35: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 36: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 37: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 38: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 39: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 40: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 41: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 42: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 43: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 44: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 45: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 46: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 47: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 48: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 49: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 50: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 51: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 52: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 53: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 54: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 55: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 56: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 57: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 58: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 59: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 60: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 61: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 62: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 63: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 64: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 65: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 66: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 67: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 68: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 69: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 70: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 71: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 72: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 73: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 74: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 75: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 76: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 77: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 78: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 79: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 80: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 81: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 82: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 83: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 84: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the European In Vitro Diagnostics Market?
The projected CAGR is approximately 7.9%.
2. Which companies are prominent players in the European In Vitro Diagnostics Market?
Key companies in the market include Becton Dickinson and Company, BioMerieux SA, Tesa SE, Bio-Rad Laboratories Inc, Illumina Inc , Siemens Healthcare, Hologic Inc, Thermo Fisher Scientific Inc, Abbott Laboratories, Diasorin S p A, Danaher Corporation (Beckman Coulter Inc), Sysmex Corporation, QIAGEN, Roche Diagnostics.
3. What are the main segments of the European In Vitro Diagnostics Market?
The market segments include Test Type, Product, Usability, Application, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 21.19 billion as of 2022.
5. What are some drivers contributing to market growth?
High Prevalence of Chronic Diseases; Increasing Demand for Point-of-care Diagnostics; Technological Advancements in In-Vitro Diagnostics Devices.
6. What are the notable trends driving market growth?
The Instrument Segment is Expected to Hold a Major Share in the Market.
7. Are there any restraints impacting market growth?
Stringent Regulations; Cumbersome Reimbursement Procedures.
8. Can you provide examples of recent developments in the market?
In March 2023, MGI Tech Co., Ltd. received the CE mark for the DNBSeq-G99 sequencer with an aim to precise sequencing of genetic substances.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "European In Vitro Diagnostics Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the European In Vitro Diagnostics Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the European In Vitro Diagnostics Market?
To stay informed about further developments, trends, and reports in the European In Vitro Diagnostics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence